Emmanuelle Boutmy

493 total citations
40 papers, 301 citations indexed

About

Emmanuelle Boutmy is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Emmanuelle Boutmy has authored 40 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Emmanuelle Boutmy's work include Polyomavirus and related diseases (10 papers), Lung Cancer Treatments and Mutations (8 papers) and Economic and Financial Impacts of Cancer (6 papers). Emmanuelle Boutmy is often cited by papers focused on Polyomavirus and related diseases (10 papers), Lung Cancer Treatments and Mutations (8 papers) and Economic and Financial Impacts of Cancer (6 papers). Emmanuelle Boutmy collaborates with scholars based in Germany, France and United States. Emmanuelle Boutmy's co-authors include Matthieu Schmidt, Alexandre Demoule, Thomas Similowski, Martin Dres, Mathieu Raux, Félix Kindler, Julien Mayaux, M. Bagot, J. Just and Flore Amat and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Emmanuelle Boutmy

37 papers receiving 295 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emmanuelle Boutmy Germany 9 107 63 46 43 42 40 301
H. Grech United Kingdom 8 43 0.4× 36 0.6× 3 0.1× 33 0.8× 18 0.4× 16 316
Brankica Spasojević Serbia 11 87 0.8× 9 0.1× 8 0.2× 21 0.5× 6 0.1× 22 261
J. Stinson Ireland 9 21 0.2× 15 0.2× 13 0.3× 27 0.6× 2 0.0× 25 336
Charles Rodeck United Kingdom 4 58 0.5× 9 0.1× 2 0.0× 36 0.8× 35 0.8× 6 332
Gökhan Aksan Türkiye 14 37 0.3× 53 0.8× 3 0.1× 36 0.8× 7 0.2× 43 445
Nathan Hambly Canada 14 412 3.9× 24 0.4× 14 0.3× 200 4.7× 4 0.1× 35 524
Sara Tehrani Sweden 10 39 0.4× 46 0.7× 6 0.1× 55 1.3× 15 0.4× 16 278
Edmundo Rubio United States 11 127 1.2× 42 0.7× 26 0.6× 29 0.7× 37 279
Erin Healy United States 9 46 0.4× 37 0.6× 1 0.0× 17 0.4× 9 0.2× 36 280
Erminia Baldacci Italy 12 40 0.4× 30 0.5× 9 0.2× 12 0.3× 4 0.1× 50 420

Countries citing papers authored by Emmanuelle Boutmy

Since Specialization
Citations

This map shows the geographic impact of Emmanuelle Boutmy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuelle Boutmy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuelle Boutmy more than expected).

Fields of papers citing papers by Emmanuelle Boutmy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuelle Boutmy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuelle Boutmy. The network helps show where Emmanuelle Boutmy may publish in the future.

Co-authorship network of co-authors of Emmanuelle Boutmy

This figure shows the co-authorship network connecting the top 25 collaborators of Emmanuelle Boutmy. A scholar is included among the top collaborators of Emmanuelle Boutmy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanuelle Boutmy. Emmanuelle Boutmy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boutmy, Emmanuelle, et al.. (2024). P-765 Minding the sweet spot in birth weight: Metformin and insulin versus no treatment. Human Reproduction. 39(Supplement_1). 1 indexed citations
2.
3.
4.
Sørup, Signe, Bianka Darvalics, Jakob S. Knudsen, et al.. (2022). Identifying Valid Algorithms for Number of Lines of Anti-Neoplastic Therapy in the Danish National Patient Registry Among Patients with Advanced Ovarian, Gastric, Renal Cell, Urothelial, and Non-Small Cell Lung Cancer Attending a Danish University Hospital. SHILAP Revista de lepidopterología. 2 indexed citations
5.
Allignol, Arthur, et al.. (2022). Effectiveness of bisoprolol versus other β-blockers and other antihypertensive classes: a cohort study in the Clinical Practice Research Datalink. Journal of Comparative Effectiveness Research. 11(6). 423–436. 4 indexed citations
6.
Boutmy, Emmanuelle, et al.. (2022). Metformin in pregnancy and risk of abnormal growth outcomes at birth: a register-based cohort study. BMJ Open Diabetes Research & Care. 10(6). e003056–e003056. 4 indexed citations
7.
Sørup, Signe, Bianka Darvalics, Azza A. Khalil, et al.. (2021). Treatment and Survival in Advanced Non-Small Cell Lung Cancer, Urothelial, Ovarian, Gastric and Kidney Cancer: A Nationwide Comprehensive Evaluation. Clinical Epidemiology. Volume 13. 871–882. 1 indexed citations
8.
Bosco‐Lévy, Pauline, Angela Grelaud, Meritxell Sabidó, et al.. (2021). Incidence and risk of cancer among multiple sclerosis patients: A matched population‐based cohort study. European Journal of Neurology. 29(4). 1091–1099. 17 indexed citations
9.
10.
Bittoni, Marisa A., James Chih‐Hsin Yang, Jin‐Yuan Shih, et al.. (2021). Real-world insights into patients with advanced NSCLC and MET alterations. Lung Cancer. 159. 96–106. 16 indexed citations
11.
Boutmy, Emmanuelle, et al.. (2021). Real-world healthcare resource utilization and costs of weekly versus every-2-week cetuximab in metastatic colorectal cancer. Journal of Comparative Effectiveness Research. 10(5). 353–364. 5 indexed citations
12.
13.
Bittoni, Marisa A., James Chih‐Hsin Yang, Nir Peled, et al.. (2020). 399P Real-world insights into patients (pts) with advanced NSCLC and MET alterations. Annals of Oncology. 31. S1398–S1399. 2 indexed citations
14.
Batech, Michael, et al.. (2020). Overall survival of cetuximab administered every two weeks versus weekly in real-world data of U.S. patients with metastatic colorectal cancer.. Journal of Clinical Oncology. 38(4_suppl). 23–23. 2 indexed citations
15.
16.
Kearney, Mairead, et al.. (2018). PCN127 - DIRECT HEALTHCARE COSTS BY TREATMENT AMONG PATIENTS WITH MERKEL CELL CARCINOMA (MCC) IN THE UNITED STATES. Value in Health. 21. S36–S36. 1 indexed citations
17.
18.
Boutmy, Emmanuelle, et al.. (2015). A Cross-Sectional Study on Insulin Treatments and Glycemic Control in Type 2 Diabetes in France, Italy, Germany, UK and Spain. Value in Health. 18(7). A599–A599. 3 indexed citations
19.
Amat, Flore, Philippe Pierre, E. Bourrat, et al.. (2015). Early-Onset Atopic Dermatitis in Children: Which Are the Phenotypes at Risk of Asthma? Results from the ORCA Cohort. PLoS ONE. 10(6). e0131369–e0131369. 38 indexed citations
20.
Schmidt, Matthieu, Martin Dres, Mathieu Raux, et al.. (2012). Neurally adjusted ventilatory assist improves patient–ventilator interaction during postextubation prophylactic noninvasive ventilation*. Critical Care Medicine. 40(6). 1738–1744. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. Grech Breakdown of academic impact, for papers by Brankica Spasojević Breakdown of academic impact, for papers by J. Stinson Breakdown of academic impact, for papers by Charles Rodeck Breakdown of academic impact, for papers by Gökhan Aksan Breakdown of academic impact, for papers by Nathan Hambly Breakdown of academic impact, for papers by Sara Tehrani Breakdown of academic impact, for papers by Edmundo Rubio Breakdown of academic impact, for papers by Erin Healy Breakdown of academic impact, for papers by Erminia Baldacci
Rankless by CCL
2026